Literature DB >> 12368320

The major phosphorylation sites of the respiratory syncytial virus phosphoprotein are dispensable for virus replication in vitro.

Bin Lu1, Chien-Hui Ma, Robert Brazas, Hong Jin.   

Abstract

The phosphoprotein (P protein) of respiratory syncytial virus (RSV) is a key component of the viral RNA-dependent RNA polymerase complex. The protein is constitutively phosphorylated at the two clusters of serine residues (116, 117, and 119 [116/117/119] and 232 and 237 [232/237]). To examine the role of phosphorylation of the RSV P protein in virus replication, these five serine residues were altered to eliminate their phosphorylation potential, and the mutant proteins were analyzed for their functions with a minigenome assay. The reporter gene expression was reduced by 20% when all five phosphorylation sites were eliminated. Mutants with knockout mutations at two phosphorylation sites (S232A/S237A [PP2]) and at five phosphorylation sites (S116L/S117R/S119L/S232A/S237A [PP5]) were introduced into the infectious RSV A2 strain. Immunoprecipitation of (33)P(i)-labeled infected cells showed that P protein phosphorylation was reduced by 80% for rA2-PP2 and 95% for rA2-PP5. The interaction between the nucleocapsid (N) protein and P protein was reduced in rA2-PP2- and rA2-PP5-infected cells by 30 and 60%, respectively. Although the two recombinant viruses replicated well in Vero cells, rA2-PP2 and, to a greater extent, rA2-PP5, replicated poorly in HEp-2 cells. Virus budding from the infected HEp-2 cells was affected by dephosphorylation of P protein, because the majority of rA2-PP5 remained cell associated. In addition, rA2-PP5 was also more attenuated than rA2-PP2 in replication in the respiratory tracts of mice and cotton rats. Thus, our data suggest that although the major phosphorylation sites of RSV P protein are dispensable for virus replication in vitro, phosphorylation of P protein is required for efficient virus replication in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368320      PMCID: PMC136636          DOI: 10.1128/jvi.76.21.10776-10784.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system.

Authors:  M S Slack; A J Easton
Journal:  Virus Res       Date:  1998-06       Impact factor: 3.303

2.  Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Authors:  L S Wyatt; B Moss; S Rozenblatt
Journal:  Virology       Date:  1995-06-20       Impact factor: 3.616

3.  Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions.

Authors:  B García-Barreno; T Delgado; J A Melero
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.

Authors:  P L Collins; M G Hill; E Camargo; H Grosfeld; R M Chanock; B R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

5.  Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication.

Authors:  Q Yu; R W Hardy; G W Wertz
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

6.  Identification of a protein kinase involved in the phosphorylation of the C-terminal region of human respiratory syncytial virus P protein.

Authors:  N Villanueva; J Navarro; E Méndez; I García-Albert
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

7.  Requirement of casein kinase II-mediated phosphorylation for the transcriptional activity of human respiratory syncytial viral phosphoprotein P: transdominant negative phenotype of phosphorylation-defective P mutants.

Authors:  B Mazumder; S Barik
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

8.  RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.

Authors:  H Grosfeld; M G Hill; P L Collins
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role.

Authors:  S Barik; T McLean; L C Dupuy
Journal:  Virology       Date:  1995-11-10       Impact factor: 3.616

10.  Multimerization and transcriptional activation of the phosphoprotein (P) of vesicular stomatitis virus by casein kinase-II.

Authors:  Y Gao; J Lenard
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  24 in total

1.  Identification and characterization of the binding site of the respiratory syncytial virus phosphoprotein to RNA-free nucleoprotein.

Authors:  Marie Galloux; Gaëlle Gabiane; Julien Sourimant; Charles-Adrien Richard; Patrick England; Mohammed Moudjou; Magali Aumont-Nicaise; Jenna Fix; Marie-Anne Rameix-Welti; Jean-François Eléouët
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

2.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

Review 3.  Initiation and regulation of paramyxovirus transcription and replication.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  Virology       Date:  2015-02-13       Impact factor: 3.616

4.  Functional characterization of the major and minor phosphorylation sites of the P protein of Borna disease virus.

Authors:  Sonja Schmid; Daniel Mayer; Urs Schneider; Martin Schwemmle
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

Review 5.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Respiratory Syncytial Virus Utilizes a tRNA Fragment to Suppress Antiviral Responses Through a Novel Targeting Mechanism.

Authors:  Junfang Deng; Ryan N Ptashkin; Yu Chen; Zhi Cheng; Guangliang Liu; Thien Phan; Xiaoling Deng; Jiehua Zhou; Inhan Lee; Yong Sun Lee; Xiaoyong Bao
Journal:  Mol Ther       Date:  2015-07-09       Impact factor: 11.454

7.  Akt plays a critical role in replication of nonsegmented negative-stranded RNA viruses.

Authors:  Minghao Sun; Sandra M Fuentes; Khalid Timani; Dengyun Sun; Chris Murphy; Yuan Lin; Avery August; Michael N Teng; Biao He
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease.

Authors:  Peter L Collins; Rachel Fearns; Barney S Graham
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  N-terminal phosphorylation of phosphoprotein of vesicular stomatitis virus is required for preventing nucleoprotein from binding to cellular RNAs and for functional template formation.

Authors:  Longyun Chen; Shengwei Zhang; Amiya K Banerjee; Mingzhou Chen
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

10.  PLK1 down-regulates parainfluenza virus 5 gene expression.

Authors:  Dengyun Sun; Priya Luthra; Zhuo Li; Biao He
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.